日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Effects of heterozygous SMG1 mutations on nonsense-mediated mRNA decay in human pluripotent stem cell model.

杂合SMG1突变对人类多能干细胞模型中无义介导的mRNA衰变的影响

期刊:Molecules and Cells
影响因子:6.5
doi:10.1016/j.mocell.2025.100225
Lee Chanyoung, Lee Jin Sook, Kwon Yejin, Shin Aeri, Jeong Tae Yeong, Yang Jiyun, Hwang Jung Woo, Kim Hyeong-In, Choi Hee-Jung, Kim Yoon Ki, Choi Murim, Kim Kyoungmi, Sun Woong, Chae Jong-Hee
发育与干细胞
细胞生物学
Human
发表日期：2025
文献求助 收藏

The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer

BRCA突变位置与PARP抑制剂作为晚期上皮性卵巢癌一线维持治疗疗效之间的关联

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17050756
Kim, Ji Hyun; Kim, Se Ik; Kim, Eun Taeg; Ha, Hyeong In; Lee, Dong-Eun; Lee, Yong Jae; Lee, Jung-Yun; Kim, Sunghoon; Kim, Sang Wun; Kim, Young Tae; Park, Sang-Yoon; Lim, Myong Cheol; Nam, Eun-Ji
PARP
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Survival Outcomes Associated with the Location of BRCA Mutations in Ovarian Cancer: A Systematic Review and Meta-Analysis

卵巢癌中BRCA突变位置与生存结局相关的研究：系统评价和荟萃分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17101661
Kim, Ji Hyun; Yoon, Hyung Joon; Ha, Hyeong In; Kim, Eun Taeg; Kim, Dongkyu Eugene; Kim, Sangeon; Bae, Jae Kyung; Lim, Myong Cheol
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Influence of Residual Disease on the Efficacy of PARP Inhibitors in Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta Analysis

残余病灶对PARP抑制剂治疗晚期上皮性卵巢癌疗效的影响：系统评价和荟萃分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17203365
Hwang, Sekyoung; Kim, Ji Hyun; Kim, Uisuk; Ha, Hyeong In; Park, Sang-Yoon; Lim, Myong Cheol
PARP
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Time-Trend Analysis and Risk Factors for Niraparib-Induced Nausea and Vomiting in Ovarian Cancer: A Prospective Study

卵巢癌患者接受尼拉帕利治疗后出现恶心呕吐的时间趋势分析及危险因素：一项前瞻性研究

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2024.899
Jeong, Young Wook; Kim, Dongkyu Eugene; Kim, Ji Hyun; Kim, Se Ik; Ha, Hyeong In; Park, Sang-Yoon; Lim, Myong Cheol
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea

韩国国家癌症登记处卵巢癌肉瘤的发病率和治疗结果

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2024.35.e31
Ha, Hyeong In; Kim, Ji Hyun; Lim, Jiwon; Song, Yong Jung; Won, Young-Joo; Lim, Myong Cheol
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study

韩国子宫内膜癌发病率和生存结局趋势：一项基于全国人口的队列研究

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2024.35.e32
Shim, Seung-Hyuk; Lim, Jiwon; Kim, Ji Hyun; Lee, Yeon Jee; Ha, Hyeong In; Lim, Myong Cheol; Won, Young-Joo
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Clinical Outcomes of Poly(ADP-Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea

韩国东南部地区卵巢癌患者接受聚（ADP-核糖）聚合酶抑制剂维持治疗的临床疗效

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol31110495
Ha, Hyeong In; Yoon, Hyung Joon; Song, Changho; Kim, Eun Taeg; Suh, Dong-Soo; Kim, Ki Hyung; Na, Yong Jin; Song, Yong Jung
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Development of an Automatic Rule-Based Algorithm for the Detection of Ovarian Cancer Recurrence From Electronic Health Records

基于电子健康记录的卵巢癌复发自动检测规则算法的开发

期刊:JCO Clinical Cancer Informatics
影响因子:2.8
doi:10.1200/CCI.23.00150
Lee, Sanghee; Kim, Ji Hyun; Ha, Hyeong In; Lim, Myong Cheol; Cho, Hyunsoon
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

A high-flexion design total knee prosthesis: a ten to twelve-year follow-up study

高屈曲度全膝关节假体：一项为期10至12年的随访研究

期刊:Journal of Orthopaedic Surgery and Research
影响因子:2.8
doi:10.1186/s13018-024-05082-3
Kim, Man Soo; Choi, Keun Young; Hur, Jae Hyeong; In, Yong
发表日期：2024
文献求助 收藏